Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Parabolic Drugs IPO is a book built issue of Rs 200.00 crores.
Parabolic Drugs IPO bidding started from June 14, 2010 and ended on June 17, 2010. The shares got listed on BSE, NSE on July 1, 2010.
Parabolic Drugs IPO price band is set at ₹75 to ₹85 per share. The minimum lot size for an application is 80 Shares. The minimum amount of investment required by retail investors is ₹6,800.
ICICI Securities Limited and Spa Capital Advisors Ltd are the book running lead managers of the Parabolic Drugs IPO, while Link Intime India Private Ltd is the registrar for the issue.
Refer to Parabolic Drugs IPO RHP for detailed information.
| IPO Date | June 14, 2010 to June 17, 2010 |
| Listing Date | July 1, 2010 |
| Face Value | ₹10 per share |
| Price Band | ₹75 to ₹85 per share |
| Lot Size | 80 Shares |
| Total Issue Size | 26,666,667 shares (aggregating up to ₹200.00 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
Parabolic Drugs IPO offers 26,666,667 shares. 13,083,333 (49.06%) to QIB, 3,925,000 (14.72%) to NII, 9,158,334 (34.34%) to RII, 500,000 (1.87%) to employees. 114,479 RIIs will receive minimum 80 shares and (sNII) and (bNII) will receive minimum 2,400 shares. (in case of oversubscription)
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | - | NA |
| QIB Shares Offered | 13,083,333 (49.06%) | NA |
| NII (HNI) Shares Offered | 3,925,000 (14.72%) | |
| Retail Shares Offered | 9,158,334 (34.34%) | 114,479 |
| Employee Shares Offered | 500,000 (1.87%) | NA |
| Total Shares Offered | 26,666,667 (100%) |
Investors can bid for a minimum of 80 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 80 | ₹6,800 |
| Retail (Max) | 29 | 2320 | ₹197,200 |
| Lot Size Calculator | |||
Incorporated in 1996, Parabolic Drugs Limited is in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.
Companies product portfolio comprises 42 APIs and 7 API intermediates which are marketed domestically and exported.
Company own and operate two manufacturing facilities at Derabassi, Punjab, and Panchkula, Haryana. Company is in the process of setting up a custom synthesis and research and development (R&D) center at Barwala, Haryana.
| Particulars | For the year/period ended (Rs. in Crore) | |||||
| 30-Sept-09 | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | 31-Mar-06 | 31-Mar-05 | |
| Total Income | 233.43 | 396.94 | 273.94 | 150.56 | 90.12 | 50.90 |
| Profit After Tax (PAT) | 12.41 | 21.09 | 29.67 | 13.58 | 8.22 | 3.27 |
The objects of the issue are:
1. Multi-purpose block III at Derabassi;
2. Sterile Cephalosporin Plant (Derabassi);
3. Establishment of Chachrauli Plant;
4. Custom Synthesis & Manu. Site II at IT Park (Panchkula);
5. Repayment / Prepayment of identified loan facility;
6. General corporate purposes.
The Parabolic Drugs IPO is subscribed 1.04 times on June 17, 2010 5:00:00 PM. The public issue subscribed 0.40 times in the retail category, 1.48 times in the QIB category, and 1.20 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 1.48 |
| NII | 1.20 |
| Retail | 0.40 |
| Employee | 0.11 |
| Total | 1.04 |
| Listing Date | July 1, 2010 |
| BSE Script Code | 533211 |
| NSE Symbol | PARABDRUGS |
| ISIN | INE618H01016 |
| Final Issue Price | ₹75 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE |
|---|
| ₹75.00 |
| ₹76.00 |
| ₹63.00 |
| ₹79.00 |
| ₹64.80 |
| NSE |
|---|
| ₹75.00 |
| ₹75.00 |
| ₹63.10 |
| ₹75.95 |
| ₹64.85 |
Parabolic Drugs Limited
SCO 99-100, Sector 17-B,
Chandigarh - 160017
India
Phone: 0172 391 4646
Email: ipo@parabolicdrugs.com
Website: http://www.parabolicdrugs.com
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: pdl.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
Parabolic Drugs IPO is a main-board IPO of 26,666,667 equity shares of the face value of ₹10 aggregating up to ₹200.00 Crores. The issue is priced at ₹75 to ₹85 per share. The minimum order quantity is 80 Shares.
The IPO opens on June 14, 2010, and closes on June 17, 2010.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Parabolic Drugs IPO opens on June 14, 2010 and closes on June 17, 2010.
Parabolic Drugs IPO lot size is 80 Shares, and the minimum amount required is ₹6,800.
You can apply in Parabolic Drugs IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Parabolic Drugs IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Parabolic Drugs IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
